Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis

BACKGROUND: Due to demographic transition, multimorbidity and high numbers of medicinal products, polypharmacy rates will presumably further increase. This could lead to higher risks of potentially inappropriate medications with potential drug-drug interactions (PDDI). PDDI has already been investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Dornquast, Christina, Dombrowski, Mirja, Zabel, Markus, Willich, Stefan N., Reinhold, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106753/
https://www.ncbi.nlm.nih.gov/pubmed/32234046
http://dx.doi.org/10.1186/s12913-020-05131-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106753/
https://www.ncbi.nlm.nih.gov/pubmed/32234046
http://dx.doi.org/10.1186/s12913-020-05131-7

Ejemplares similares